Navigation Links
Boehringer Ingelheim Receives Top Honor as World's Most Respected Biopharmaceutical Employer in Science 2007 Top Employers Survey
Date:10/12/2007

RIDGEFIELD, Conn., Oct. 12 /PRNewswire/ -- Boehringer Ingelheim today announced that the company has been awarded top honors by Science as the world's most respected biopharmaceutical employer. Science's annual survey of more than 470 Top Employers polls employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries. Respondents to the web-based survey are asked to rate companies based on 23 driving characteristics, including corporate image, leadership and direction, financial strength, company culture, work/life balance, compensation, and benefits, as well as being easily adaptable to change and having a thriving research-driven environment.

"We are very pleased to be recognized as a global leader in the pharmaceutical industry by Science," said J. Martin Carroll, president and chief executive officer of Boehringer Ingelheim Corporation. "It is especially gratifying to receive this honor knowing it is a measurement of corporate reputation among both our employees and the employees of our competitors. This international recognition truly signifies that Boehringer Ingelheim is an Employer of Choice in the United States and around the world."

Over the past few years that Science has carried out this survey, Boehringer Ingelheim has climbed up in ranking, from 8th place in 2005 to second place last year. This year, Boehringer Ingelheim reached the top ranking, recognizing the company's strong commitment to innovative thinking throughout the product pipeline, from the laboratory to the marketplace, while establishing an excellent working environment.

Like Science's 2006 ranking of biopharma employers, the 2007 survey sought to identify the companies with the best reputations as employers, based on 3,157 survey responses from readers of Science and other respondents in industry. Twenty-nine percent of respondents came from outside of the United States, primarily Western Europe, and more than 90 percent worked in privat
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Lucigen receives $750K grant to boost biofuel yields
3. Medical College receives $1.4M cancer grant
4. Wisconsin biotech firm receives $107K NIH grant
5. InvivoSciences receives NIH grant for heart technology
6. Medical College receives $11 million grant to study high blood pressure
7. Madison business receives $115,000 of new state biofuels funding
8. Superior receives funds for technical training
9. UWM receives state funding for plastics research
10. GEs Centricity EHR receives federal certification
11. WHIE receives state eHealth Initiative contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...nhua-- Huifeng,Bio-Pharmace..., a leading,developer and producer of plant extrac...rmaceutical, nutraceutical and food production in ...n will be made available via,Standard & Poor,s Mar...rvice that enables subscribing publicly traded com...
(Date:7/3/2008)...- AMDL, Inc. (Amex:,ADL), a...rtered in Tustin,Ca., with operations in Shenzhen...s released its investor presentation which is avai...p://www.amdl.com ., About AMDL:, AMDL, Inc. is a...any is,headquartered in Tustin, California with op...
(Date:7/2/2008)...pany to offer choice of two distinct drugs on ... NATICK, Mass., July 2 /- ...announced that the U.S. Food and Drug,Administrati...uting,Coronary Stent System for the treatment of c...ate-labeled XIENCE(TM) V Everolimus-Eluting Corona...
(Date:7/2/2008)... /- Biopure Corporation,(Na...n agreement with,purchasers for a private placemen...million in tranches, assuming no exercise of the w...ds for working capital and general,corporate purpo...and,subsequent closings are subject to conditions ...
Breaking Biology Technology:Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program 2AMDL Announces Investor Relations Presentation Available on Website 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 3Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 4Biopure Announces Private Equity Financing 2Biopure Announces Private Equity Financing 3
...sy. If you,re the new exec, people practically exp...list, or in some "key business process." If you,re... wait too long before there,s an upgrade, a new pr...ge beast is off rummaging through the underbrush o...egins with the focus groups and Post-It-note exerc...
...d at the performance of Midwest publicly traded bi...he overall performance of the major U.S. stock ind...lar really measure the biotech sector in different...ut 20 biotech stocks (most of which are the large-...formers). No Midwest biotech companies are listed ...
...f General Electric has just been ranked the number...the 11th Annual Healthcare Informatics 100 publish...tics , where companies are ranked by their health ...re Informatics asks over the 1,700 companies regis...e IT earnings for the previous year. The data is c...
...r two years, the Wisconsin Life Sciences and Vent...al Device Conference have decided to go their sep...nd themes, these autumn conferences are now being ... partner at Venture Investors LCC and member of ...iginally combined to set Wisconsins event apart fr...
Other Biology Technology:Domesticating the change beast 2Domesticating the change beast 3VC Community Shares Perspectives on Midwest Life Science Funding 2VC Community Shares Perspectives on Midwest Life Science Funding 3VC Community Shares Perspectives on Midwest Life Science Funding 4Wisconsin giant continues to dominate the health care IT market 2Life science VC and biotech confabs to fly solo this fall 2
(Date:7/2/2008)...am has published the first clear example of how cl...ases that are normally tolerated singly may conver... In a report issued June 25 by PLoS ONE, an onli...mined outbreaks of canine distemper virus (CDV) in...tality in Serengeti lions. CDV cycles periodically...
(Date:7/2/2008)...many and the U.K. have discovered that our own bod... active ingredient in marijuana (THC), but these ...n. This finding on "endocannabinoids" just publish...rint issue of, The FASEB Journal could lead to n...cne to dry skin, and even skin-related tumors. ,...
(Date:7/2/2008)...lorida State University faculty member who uses co...cancer-killing drugs is attracting worldwide atten... assistant professor of chemical and biomedical en...ate University College of Engineering, is using hi...nown as recombinant immunotoxins can best be modif...
(Date:7/2/2008)...a State University have found that quantum dot nan...brasion, providing insight into potential workplac...nvolved in the manufacturing of quantum dots or do...of the tiny nanoparticles. , While the study sh...nd surface coatings do not penetrate rat skin unle...
Breaking Biology News(10 mins):FSU researcher using computers to hone cancer-fighting strategies 2Study shows quantum dots can penetrate skin through minor abrasions 2American Chemical Societys Weekly PressPac Feb 13 2008 12134 1American Chemical Societys Weekly PressPac Feb 13 2008 12134 2American Chemical Societys Weekly PressPac Feb 13 2008 12134 3American Chemical Societys Weekly PressPac Feb 13 2008 12134 4American Chemical Societys Weekly PressPac Feb 13 2008 12134 5American Chemical Societys Weekly PressPac Feb 13 2008 12134 6American Chemical Societys Weekly PressPac Feb 13 2008 12134 7American Chemical Societys Weekly PressPac Feb 13 2008 12134 8American Chemical Societys Weekly PressPac Feb 13 2008 12134 9Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 3353 1Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 3353 2Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 3353 3Into the abyss 3A Deep sixing carbon 2249 1Into the abyss 3A Deep sixing carbon 2249 2Mindray to Report Fourth Quarter and Fiscal Year 2007 Financial Results on March 5 2008 12126 1Mindray to Report Fourth Quarter and Fiscal Year 2007 Financial Results on March 5 2008 12126 2
...vey of U.S. adults has found that a majority belie...ling the global AIDS epidemic and are confident su...urveyed felt it personally important to help suppo...ctance to support a friend or family member’s part...e were among the conflicting findings of a telepho...
...salamanders at a Georgia military base are the gui...hers whose goal is to develop methods to better de...ot finding any flatwoods salamanders since 2001, F...re looking for a better survey method, said Mark B...,s Environmental Sciences Division. A Strategic En...
...rchers at the University of Minnesota have identif...t the development and function of blood stem cells...r to harnessing the power of stem cells for diseas... and differentiate to generate approximately 200 b...s. To maintain their numbers over time, blood stem...
...e of the largest adult vaccine clinical trials eve...cine against shingles (zoster vaccine) prevented a...d skin infection--and dramatically reduced its sev...got the disease. The findings appear in the June 2...he Shingles Prevention Study, conducted over 5 ½-y...
Other Biology News:Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research 2Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research 3Elusive salamanders have role in developing new sampling models 2Elusive salamanders have role in developing new sampling models 3Fish and chips: A fast track to understanding blood development 2Experimental shingles vaccine proves effective in nationwide study 2Experimental shingles vaccine proves effective in nationwide study 3Experimental shingles vaccine proves effective in nationwide study 4
Golgi Sampler Kit 10g each
AMAP Multi Site-directed Mutagenesis Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: dry ice
Human peripheral blood eosinophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes
Human peripheral blood PBMCs, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells
Biology Products: